Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis, Secondary Progressive”

172 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 172 results

Large-scale testing (Phase 3)Ended earlyNCT04925557
What this trial is testing

Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary-progressive Multiple Sclerosis
State University of New York at Buffalo 8
Large-scale testing (Phase 3)Temporarily pausedNCT05441488
What this trial is testing

Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
AB Science 800
Not applicableStudy completedNCT04918225
What this trial is testing

Motor Asymmetry in Progressive Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
Rennes University Hospital 46
Post-approval studies (Phase 4)Study completedNCT02208050
What this trial is testing

The Effectiveness of Fampridine in Improving Upper Limb Function in MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
University College Dublin 64
Testing effectiveness (Phase 2)WithdrawnNCT03696485
What this trial is testing

Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS

Who this might be right for
Secondary Progressive Multiple Sclerosis (SPMS)
Stem Cell Medicine Ltd.
Testing effectiveness (Phase 2)UnknownNCT01466114
What this trial is testing

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary-progressive Multiple SclerosisPrimary-progressive Multiple Sclerosis
University of California, Los Angeles 64
Not applicableLooking for participantsNCT07355387
What this trial is testing

Home Based Functional Balance Intervention for Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+2 more
University of Illinois at Chicago 75
Early research (Phase 1)Ended earlyNCT01144351
What this trial is testing

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Elan Pharmaceuticals 32
Not applicableStudy completedNCT03094364
What this trial is testing

Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisHemiparesis
University of Massachusetts, Lowell 31
Testing effectiveness (Phase 2)Looking for participantsNCT07477639
What this trial is testing

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis (SPMS)Multiple Sclerosis+2 more
Tr1X, Inc. 39
Early research (Phase 1)Study completedNCT03493841
What this trial is testing

Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis

Who this might be right for
Multiple SclerosisProgressive Multiple SclerosisSecondary Progressive Multiple Sclerosis+1 more
Rebecca Spain 20
Large-scale testing (Phase 3)Ended earlyNCT00870155
What this trial is testing

Patients With Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Eli Lilly and Company 546
Large-scale testing (Phase 3)Looking for participantsNCT07225504
What this trial is testing

Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis (SPMS)
Novartis Pharmaceuticals 1,275
Not applicableStudy completedNCT00888277
What this trial is testing

Bayer/Cognitive Assessments With Multiple Sclerosis Subjects

Who this might be right for
Multiple Sclerosis, Relapsing-remittingMultiple Sclerosis, Secondary Progressive
University of Louisville 74
Not applicableStudy completedNCT01737372
What this trial is testing

A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis

Who this might be right for
Multiple SclerosisSecondary Progressive Multiple SclerosisClinically Isolated Syndrome
John F. Foley, MD 49
Testing effectiveness (Phase 2)Study completedNCT01077466
What this trial is testing

Natalizumab Treatment of Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis
Rigshospitalet, Denmark 24
Not applicableStudy completedNCT03935529
What this trial is testing

Behavioural Activation for Low Mood in Multiple Sclerosis

Who this might be right for
DepressionSecondary-progressive Multiple Sclerosis
University of Lincoln 10
Testing effectiveness (Phase 2)Study completedNCT00342134
What this trial is testing

Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 34
Early research (Phase 1)Study completedNCT01381354
What this trial is testing

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

Who this might be right for
Multiple Sclerosis
University of Iowa 38
Post-approval studies (Phase 4)Ended earlyNCT01411514
What this trial is testing

Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Claudio Gobbi 27
Load More Results